Utah Hands Psych Med Refills to an AI Chatbot—Doctors Aren't Buying It
Picture snapping a photo of your Prozac bottle to a chatbot for a refill. Utah just greenlit that—sparking fury from doctors who say it's risky and solves the wrong problem.
⚡ Key Takeaways
- Utah's AI pilot renews select psych meds for stable patients only, excluding complex cases.
- Psychiatrists criticize opacity, over-treatment risks, and minimal access gains.
- Echoes 1980s AI medicine hype that failed on explainability—lawsuits loom.
Worth sharing?
Get the best AI stories of the week in your inbox — no noise, no spam.
Originally reported by The Verge - AI